Article | June 16, 2020

What Is ICH E6(R2)?

Key Considerations For ICH-GCP Guidance On Quality Risk Management

ICH E6(R2) is an addendum to the International Council for Harmonisation E6(R1) that provides Good Clinical Practice (GCP) guidance and “a unified standard for the European Union, Japan, and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in those jurisdictions.”

The guidance was updated in March 2018 and one section outlines sponsors’ oversight responsibilities when clinical studies are outsourced to contract research organizations (CROs). Section 5.2.1 of the guidance states “A sponsor may transfer any or all of the sponsor’s trial-related duties and functions to a CRO, but the ultimate responsibility for the quality and integrity of the trial data always resides with the sponsor.”

Regulatory bodies can issue major or critical findings for non-compliance, so study oversight is critical for outsourced clinical trials.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: